Webinar | Cardiovascular Ultrasound| August 27, 2021

WEBINAR: Echocardiographic Strain Assessment in a Contemporary Cardiology Practice

Sponsored by Siemens and Epsilon Imaging


This educational webinar is focused on the value echocardiographic strain imaging brings to a contemporary cardiology practice presented by Anya Narezkina, M.D. She is an assistant clinical professor, Division of Cardiovascular Medicine and director of the Cardio-Oncology Program at the University of California San Diego Cardiovascular Institute. 

The webinar takes place Sept. 21, at 3 p.m. eastern time / 2 p.m. central time.

The webinar will cover the importance of myocardial strain imaging and current guidelines recommended by the American Society of Echocardiography (ASE). Additionally, it will focus on the development of a comprehensive cardio-oncology program and the utility of strain imaging for diagnostic and surveillance for cardiotoxicity as well as other clinical indications. The webinar will conclude with a look into the future of strain imaging for echocardiography, followed by a Q & A session.

Register for this Webinar

Learning Objectives:

• Staying abreast of the current guidelines on strain imaging

• Understanding the utility of echo strain assessment in clinical practice

• Proper utilization of strain applications in cardio-oncology

• Understanding the value of strain imaging for prognostication in the clinical setting

Speaker Profile:

Anya Narezkina, M.D. Assistant Clinical Professor, Division of Cardiovascular Medicine Director of the Cardio-Oncology Program University of California San Diego Cardiovascular InstituteAnya Narezkina, M.D.
Assistant Clinical Professor, Division of Cardiovascular Medicine
Director of the Cardio-Oncology Program
University of California San Diego Cardiovascular Institute

Narezkina is a board-certified cardiologist who specializes in cardio-oncology. As director of the cardio-oncology program at UC San Diego Health, She works in close collaboration with oncologists to address the heart needs of patients undergoing chemotherapy, targeted cancer therapy, immunotherapy, radiation therapy or bone marrow transplantation. Her research has focused on understanding risks of cardiac complications with cancer therapies.

Narezkina also collaborates with bioengineering department at UC San Diego on developing novel imaging approaches for early diagnosis of cardiotoxicity in patients treated with chemotherapy. 

She completed a fellowship in cardiology and a residency in internal medicine and at UC San Diego School of Medicine. She earned her medical degree from the Smolensk State Medical Academy in Russia. She is board certified in internal medicine and cardiovascular disease. Narezkina is also certified by the National Board of Echocardiography in adult comprehensive echocardiography.

Company Profiles:

 

Epsilon Imaging
Epsilon Imaging is a provider of workflow enhancing solutions for cardiology based in Ann Arbor, Michigan, USA, and is transforming cardiac diagnostic workflow with a vendor neutral suite of software applications designed for echocardiography. EchoInsight provides a suite of clinical applications that provide visualization and analysis with practical strain imaging for the clinical environment. Applications assist clinicians to improve, standardize, and streamline interpretation and reporting of echo studies. Clinical applications include LV, LV Contrast, RV, Full Heart and Stress Echo.

Siemens Healthineers
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey toward expanding precision medicine, transforming care delivery, and improving patient experience, all made possible by digitalizing healthcare. An estimated 5 million patients globally benefit every day from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics, and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 120 years of experience and 18,500 patents globally. Through the dedication of more than 50,000 dedicated colleagues in 70 countries, we will continue to innovate and shape the future of healthcare.

 

Register for this Webinar

Related Content

This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S.
Webinar | Cardiovascular Ultrasound | August 27, 2021
Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography
While doctors have used low-intensity ultrasound as a medical imaging tool since the 1950s, experts at the University of Waterloo are using and extending models that help capture how high-intensity focused ultrasound (HIFU) can work on a cellular level.

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. 

News | Focused Ultrasound Therapy | August 24, 2021
August 24, 2021 — Researchers are bringing the use of acoustic waves to target and destroy cancerous tumors closer to
Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery.

Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One.

Feature | Ultrasound Imaging | July 28, 2021
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in engin
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volum

In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volume. Image courtesy of Washington University in St. Louis

News | Magnetic Resonance Imaging (MRI) | July 13, 2021
July 13, 2021 — ...